A 4-Year Observational Cohort Study to Evaluate the Efficacy of Ipilimumab in Patients With Treatment-Naive Advanced Melanoma with and without Brain Metastases
Latest Information Update: 22 Jan 2016
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 22 Jan 2016 New trial record